Post-Translational Modification Proteomics: Analysis of Detection Principles and Enrichment Strategies
-
Aberrant phosphorylation is associated with cancer and diabetes;
-
Dysfunction in the ubiquitination pathway is a hallmark of numerous neurodegenerative disorders;
-
Acetylation and deacetylation are tightly linked to epigenetic regulation.
Post-translational modifications (PTMs) play a central role in regulating cellular functions and are extensively involved in biological processes such as signal transduction, cell cycle control, and metabolic reprogramming. Systematic investigation of PTM dynamics is critical for understanding disease mechanisms and identifying biomarkers. With the rapid advancements in mass spectrometry (MS), PTM proteomics has emerged as a pivotal tool in life science research. This review focuses on the principles of PTM detection and enrichment strategies, providing a comprehensive overview of the core workflow from sample preparation to data acquisition.
What Are Post-Translational Modifications? Why Is Studying PTMs Critical?
Post-translational modifications refer to covalent modifications of proteins catalyzed by enzymes after translation, including phosphorylation, acetylation, ubiquitination, methylation, glycosylation, and others. A single protein can undergo multiple types of modifications, enabling dynamic regulation in both spatial and temporal contexts. PTMs are deeply implicated in various disease processes. For instance:
Each type of PTM is characterized by distinct enzymatic machinery, substrate specificity, and biological functions. Moreover, PTMs often act in combination to modulate protein activity, collectively forming what is referred to as the PTM code.
Principles and Workflow of Mass Spectrometry in PTM Detection
Mass spectrometry enables the identification, site-specific localization, and quantitative analysis of PTM-containing peptides by measuring mass shifts and the structural features of fragment ions. The core workflow of post-translational modification proteomics involves the following steps:
1. Sample Pretreatment and Digestion
Protein samples are subjected to lysis, reduction, and alkylation, followed by enzymatic digestion—typically using trypsin—into peptides. Since PTM-modified peptides represent only a minor fraction of the total peptide pool, enrichment strategies are essential to improve analytical sensitivity.
2. Enrichment
To selectively isolate peptides bearing specific modifications (e.g., phosphorylation, acetylation), physicochemical or immunoaffinity-based enrichment methods are applied prior to MS analysis to minimize interference from complex sample matrices.
3. LC-MS/MS Detection
Enriched PTM peptides are analyzed using high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS), employing platforms such as Orbitrap or timsTOF. Both precursor ion (MS1) and fragment ion (MS2) spectra are acquired for downstream interpretation.
4. Data Analysis and Site Localization
PTM site identification and quantification are carried out using curated modification databases (e.g., UniMod) and specialized software platforms (e.g., MaxQuant, Proteome Discoverer, DIA-NN). These tools perform site matching, confidence scoring (e.g., PTM Score), and quantitative comparisons via approaches such as label-free quantification, tandem mass tags (TMT), or data-independent acquisition (DIA).
Analysis of Enrichment Strategies for Mainstream PTM Types
1. Enrichment of Phosphorylated Peptides
Phosphorylation is among the most extensively studied post-translational modifications, typically occurring on serine, threonine, and tyrosine residues. The primary enrichment strategies include:
(1) Immobilized Metal Ion Affinity Chromatography (IMAC): Utilizing Fe³⁺ or Ga³⁺ as immobilized stationary phases to selectively capture phosphate groups;
(2) Metal Oxide Affinity Chromatography (MOAC): Nanomaterials such as TiO₂ and ZrO₂ enable effective enrichment of phosphorylated peptides;
(3) Sequential Enrichment: Combining multiple enrichment steps such as strong cation exchange chromatography and TiO₂-based methods to enhance depth of phosphoproteomic coverage.
2. Enrichment of Ubiquitinated Peptides
Ubiquitination plays crucial roles in regulating the cell cycle, protein degradation, and immune responses. Following trypsin digestion, ubiquitinated lysine residues typically retain a di-glycine remnant (K-ε-GG).
(1) K-ε-GG-specific antibody enrichment: Enables highly specific recognition of ubiquitination sites;
(2) MS³-tiered fragmentation strategies: Facilitate the precise identification of specific ubiquitin chain linkages (e.g., K48, K63).
3. Enrichment of Acetylated and Methylated Peptides
(1) Antibody affinity enrichment: Selective isolation using modification-specific antibodies (e.g., anti-Acetyl-Lys, anti-Methyl-Arg);
(2) Hydrophilic Interaction Liquid Chromatography (HILIC): Allows partial resolution of peptides bearing weakly polar modifications.
4. Co-Enrichment of Multiple Modifications
For studies addressing the crosstalk among multiple post-translational modifications (e.g., phospho-acetyl-ubiquitin regulation), strategies integrating serial enrichment workflows, multistage mass spectrometry (MSⁿ), and data-independent acquisition (DIA) are employed. MtoZ Biolabs utilizes cutting-edge mass spectrometry platforms, including Thermo Orbitrap Exploris and Bruker timsTOF, along with deeply optimized DDA and DIA protocols, to ensure comprehensive profiling of complex PTM landscapes.
Impact of Mass Spectrometry Acquisition Modes on PTM Research
1. DDA Mode: A Classical Approach in Modification Proteomics
Data-Dependent Acquisition (DDA), which employs a top-N precursor ion selection strategy, has been extensively utilized for constructing PTM spectral libraries and achieving high-precision site localization. However, it exhibits inherent bias against low-abundance peptides and demonstrates limited reproducibility across biological replicates.
2. DIA Mode: An Emerging Trend for High-Reproducibility PTM Profiling
Data-Independent Acquisition (DIA) enhances detection consistency and sensitivity by implementing comprehensive MS1 scans followed by windowed MS/MS fragmentation. This approach is particularly advantageous for analyzing clinical specimens, large-scale time-series datasets, and drug intervention experiments. When paired with experiment-specific spectral libraries, DIA can markedly improve both the depth and accuracy of PTM detection.
MtoZ Biolabs adopts an integrated DDA and DIA strategy for PTM analysis, which has been successfully applied in diverse research areas including tumor immunology, metabolic disorders, and epigenetic regulation.
Data Analysis Strategies and Biological Interpretation Framework for Post-Translational Modification Proteomics
1. Site Localization Confidence Scoring (e.g., PTM Score, Ascore): Used to ensure the precise assignment of post-translational modification sites.
2. Differential Modification Screening: Identifies condition-specific modification sites based on statistical parameters such as fold change and p-value.
3. Pathway Enrichment Analysis: Employs annotation databases such as GO, KEGG, and PANTHER to determine biological pathways associated with modified proteins.
4. Interaction Network Construction: Leverages tools like STRING and Cytoscape to build protein–protein interaction networks among modified proteins.
5. Cross-Modifications Analysis: Investigates potential synergistic or antagonistic regulatory mechanisms among different types of post-translational modifications.
PTM Proteomics Platform Capabilities at MtoZ Biolabs
As a specialized mass spectrometry service platform focused on proteomics, MtoZ Biolabs has developed a standardized and systematic workflow for post-translational modification proteomics, offering the following key capabilities:
1. Comprehensive Modification Coverage: Supports major PTM types including phosphorylation, acetylation, ubiquitination, and methylation.
2. Multi-Platform Mass Spectrometry Infrastructure: Features high-resolution MS systems including Orbitrap Exploris, timsTOF, and TripleTOF.
3. Broad Sample Compatibility: Compatible with a wide range of sample types including cultured cells, tissues, plasma, FFPE samples, as well as human and model organisms.
4. Tailored Enrichment Strategies: Customized selection of enrichment reagents and workflows based on project-specific requirements.
5. Advanced Bioinformatics Support: End-to-end data analysis pipeline covering site identification, statistical filtering, pathway analysis, and network visualization; outputs are designed to meet publication standards in peer-reviewed journals.
6. Data Reusability and Integrative Analysis Potential: Provides a robust data foundation for subsequent multi-modification and multi-omics integration from the same sample set.
Post-translational modification proteomics has progressed from early single-site identification efforts to a new era of comprehensive, network-based, and multi-dimensional analysis. Centered on advanced mass spectrometry and supported by optimized enrichment strategies and computational algorithms, PTM studies are playing an increasingly critical role in uncovering the dynamic regulatory mechanisms of biological systems. With the maturation of DIA-MS technologies, the integration of AI-assisted modification identification algorithms, and continuous updates to PTM pathway databases, this field is becoming increasingly relevant to research on cancer, immune function, autoimmune disorders, and neurodegenerative diseases. MtoZ Biolabs remains committed to advancing its proteomics platform and analytical services to deliver high-quality, reproducible, and publication-ready PTM solutions. Researchers are welcome to contact us for customized service proposals and to collaboratively advance high-precision life science research.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
